Search

Displaying results 9811 - 9820 of 10000 in total
  1. Drug

    Vornorexant

    go.drugbank.com/drugs/DB21483
    Experimental

    The usage of the INN stem '-orexant' in the name indicates that Vornorexant is a orexin receptor antagonist. Vornorexant has a monoisotopic molecular weight of 447.18 Da.

  2. Drug

    Enuvaptan

    go.drugbank.com/drugs/DB21492
    Experimental

    The usage of the INN stem '-vaptan' in the name indicates that Enuvaptan is a vasopressin receptor antagonist. Enuvaptan has a monoisotopic molecular weight of 576.09 Da.

  3. Drug

    Xininurad

    go.drugbank.com/drugs/DB21564
    Experimental

    The usage of the INN stem '-inurad' in the name indicates that Xininurad is a urate transporter inhibitor. Xininurad has a monoisotopic molecular weight of 440.91 Da.

  4. Drug

    Ansornitinib

    go.drugbank.com/drugs/DB21577
    Experimental

    The usage of the INN stem '-tinib' in the name indicates that Ansornitinib is a tyrosine kinase inhibitor. Ansornitinib has a monoisotopic molecular weight of 540.25 Da.

  5. Drug

    Garsorasib

    go.drugbank.com/drugs/DB21581
    Investigational

    The usage of the INN stem '-rasib' in the name indicates that Garsorasib is a Ras protein inhibitor. Garsorasib has a monoisotopic molecular weight of 598.26 Da.

  6. Drug

    Gumelutamide

    go.drugbank.com/drugs/DB21615
    Experimental

    The usage of the INN stem '-lutamide' in the name indicates that Gumelutamide is a non-steroid antiandrogen. Gumelutamide has a monoisotopic molecular weight of 420.15 Da.

  7. Drug

    Frevecitinib

    go.drugbank.com/drugs/DB21681
    Investigational

    The usage of the INN stem '-citinib' in the name indicates that Frevecitinib is a Janus kinase inhibitor. Frevecitinib has a monoisotopic molecular weight of 415.18 Da.

  8. Drug

    Odentegravir

    go.drugbank.com/drugs/DB21708
    Experimental

    The usage of the INN stem '-tegravir' in the name indicates that Odentegravir is a HIV integrase inhibitor. Odentegravir has a monoisotopic molecular weight of 421.12 Da.

  9. Drug

    Triplizumab

    go.drugbank.com/drugs/DB30669
    Investigational

    triplizumab is a biologic drug. triplizumab is under investigation in clinical trial NCT06486220 (PFLL Combined With PD-1 Antibody With or Without FMT for Oligometastatic NPC,a Phase III ,Open, Randomized

  10. Drug

    Imisopasem manganese

    go.drugbank.com/drugs/DB04976
    Investigational

    M40403 is a low molecular weight, synthetic manganese containing superoxide dismutase mimetic (SODm) that selectively removes superoxide anion.